|
Delayed
London S.E.
11:35:38 2018-05-22 EDT
|
5-day change | 1st Jan Change | ||
| 0.4170 EUR | -0.48% |
|
-.--% | - |
| 09-10 | Klea Pharmaceuticals Receives First Order from Alphamed and Expands Distribution in the Middle East | CI |
| 09-09 | Klea Holding Launches Wellness Brand in Dubai | MT |
Company Valuation: Visiomed Group
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 22.43 | 11.49 | 82.47 | 83.28 | 54.4 | 67.23 |
| Change | - | -48.76% | 617.6% | 0.98% | -34.68% | 23.59% |
| Enterprise Value (EV) 1 | 21.66 | 9.877 | 85.72 | 88.24 | 56.97 | 67.36 |
| Change | - | -54.4% | 767.9% | 2.93% | -35.43% | 18.23% |
| P/E | -3.19x | -1.33x | -22.7x | 94.3x | 44.3x | 31.3x |
| PBR | -5.08x | 0.92x | 4.94x | 3.45x | 1.94x | 2.44x |
| PEG | - | 0x | 0.3x | -1x | 1.3x | 0.4x |
| Capitalization / Revenue | 1.18x | 1.6x | 5.71x | 6.08x | 3.15x | 3.03x |
| EV / Revenue | 1.14x | 1.38x | 5.93x | 6.44x | 3.3x | 3.04x |
| EV / EBITDA | -3.49x | -3.43x | -57.8x | 46.6x | 15.9x | 13x |
| EV / EBIT | -3.29x | -2.69x | -21x | 223x | 29.3x | 18.3x |
| EV / FCF | -2.45x | 3.8x | -5.36x | -181x | 129x | 24.2x |
| FCF Yield | -40.8% | 26.3% | -18.7% | -0.55% | 0.78% | 4.14% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.2766 | -0.0706 | -0.0179 | 0.003 | 0.004 | 0.006999 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 19.02 | 7.179 | 14.44 | 13.71 | 17.26 | 22.17 |
| EBITDA 1 | -6.199 | -2.876 | -1.484 | 1.892 | 3.573 | 5.187 |
| EBIT 1 | -6.581 | -3.677 | -4.082 | 0.395 | 1.947 | 3.678 |
| Net income 1 | -5.15 | -4.457 | -5.277 | 0.902 | 1.405 | 2.281 |
| Net Debt 1 | -0.766 | -1.615 | 3.256 | 4.961 | 2.575 | 0.125 |
| Reference price 2 | 0.8830 | 0.0942 | 0.4075 | 0.2830 | 0.1770 | 0.2190 |
| Nbr of stocks (in thousands) | 25,400 | 121,996 | 202,373 | 294,269 | 307,327 | 306,988 |
| Announcement Date | 3/31/21 | 4/1/22 | 4/26/23 | 4/30/24 | 4/25/25 | 4/23/26 |
1EUR in Million2EUR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 12.93x | 0.4x | 8.29x | 2.99% | 114B | ||
| 14.45x | 1.81x | 9.06x | 0.73% | 92.6B | ||
| 14.02x | 1.52x | 9.19x | 2.55% | 29.66B | ||
| 24.25x | 2.69x | 13.61x | 1.34% | 27.2B | ||
| 31.69x | 5.72x | 23.83x | 2.2% | 21.43B | ||
| 7.95x | 1.43x | 6.5x | -.--% | 21.1B | ||
| 17.11x | 1.57x | 7.89x | 4.62% | 15.71B | ||
| 13.33x | 0.98x | 5.5x | 3.69% | 11.76B | ||
| 12.62x | 1.59x | 7.72x | 0.91% | 11.73B | ||
| Average | 16.48x | 1.97x | 10.18x | 2.11% | 38.31B | |
| Weighted average by Cap. | 15.38x | 1.56x | 9.72x | 2.01% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALKLH Stock
- 0D13 Stock
- Valuation Visiomed Group
Select your edition
All financial news and data tailored to specific country editions
















